In vitro cellular drug sensitivity at diagnosis is correlated to minimal residual disease at end of induction therapy in childhood acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

In vitro cellular drug sensitivity at diagnosis is correlated to minimal residual disease at end of induction therapy in childhood acute lymphoblastic leukemia

Published:2009-01 Issue:1 Volume:33 Page:46-53
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Lönnerholm Gudmar,Thörn Ingrid,Sundström Christer,Frost Britt-Marie,Abrahamsson Jonas,Behrendtz Mikael,Heldrup Jesper,Jacobsson Stefan,Li AiHong,Olofsson Tor,Porwit Anna,Söderhäll Stefan,Larsson Rolf,Forestier Erik

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference36 articles.

1. Evolution of BFM trials for childhood ALL;Schrappe;Ann Hematol,2004

2. Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome;Nyvold;Blood,2002

3. Acute lymphoblastic leukemia;Pui;N Engl J Med,2004

4. Molecular monitoring of childhood acute lymphoblastic leukemia using antigen receptor gene rearrangements and quantitative polymerase chain reaction technology;Cazzaniga;Haematologica,2005

5. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood;van Dongen;Lancet,1998

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulatory and Anti-Inflammatory Properties of Glucocorticoids;Reference Module in Biomedical Sciences;2021

2. Relapse-associated AURKB blunts the glucocorticoid sensitivity of B cell acute lymphoblastic leukemia;Proceedings of the National Academy of Sciences;2019-02-07

3. Increasing G9a automethylation sensitizes B acute lymphoblastic leukemia cells to glucocorticoid-induced death;Cell Death & Disease;2018-10

4. Glucocorticoids and Cancer;Advances in Experimental Medicine and Biology;2015

5. Clinical impact ofin vitrocellular drug resistance on childhood acute lymphoblastic leukemia in Taiwan;Leukemia & Lymphoma;2012-03